No in-house lobbyists. The figure is what 1 outside firm reported being paid by the membership group (LD-2, rounded to $10K). This PAC gives money raised from the membership group’s members; the membership group itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodAlliance for Pharmacy Compounding reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), through 1 outside firm. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Health Issues8/8
- Pharmacy8/8
- Budget/Appropriations7/8
Bills named in the filings 5 bills, this period
From the filings
“Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations”
“Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- FDA
The House and Senate appear in every quarter; agencies in 1 of 8.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by Alliance for Pharmacy Compounding, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 48 sitting members of Congress and 2 other candidates in 2025–26.
See every candidate and member Alliance for Pharmacy Compounding gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in